Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is 2431% above its 5-year average of -4.29%, near the high end of its 5-year range (-61600.00%–100.00%).
400.00% above its 12-month average of 20.00%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
20.00%
GROSS MARGIN AVG 3Y
-154.15%
GROSS MARGIN AVG 5Y
-4.29%
GROSS MARGIN AVG 10Y
-215.12%
GROSS MARGIN AVG 15Y
-207.58%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+400.00%
CURRENT VS 3Y AVG
+164.87%
CURRENT VS 5Y AVG
+2430.84%
CURRENT VS 10Y AVG
+146.48%
CURRENT VS 15Y AVG
+148.17%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+141.66%
vs the sector median at left
Talphera, Inc.
Market Cap
$57.61M
Gross Margin
100.00%
TTM Avg
20.00%
3Y Avg
-154.15%
5Y Avg
-4.29%
Market Cap
$58.06M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$57.01M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
50.00%
5Y Avg
33.33%
Market Cap
$58.29M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$58.44M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.18M
Gross Margin
99.46%
TTM Avg
98.24%
3Y Avg
49.12%
5Y Avg
32.75%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Talphera, Inc. (TLPH) | $57.61M | 100.00% | 20.00% | -154.15% | -4.29% |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | 0.00% | 0.00% | 0.00% | 0.00% |
| Kalaris Therapeutics Inc (KLRS)vs › | $58.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | 100.00% | 100.00% | 50.00% | 33.33% |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.29M | 0.00% | 0.00% | 0.00% | 0.00% |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | 0.00% | 0.00% | 25.00% | 50.00% |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | 0.00% | 0.00% | 0.00% | 0.00% |
| Xilio Therapeutics, Inc. (XLO)vs › | $59.18M | 99.46% | 98.24% | 49.12% | 32.75% |
| OKYO Pharma Limited (OKYO)vs › | $56.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aldeyra The (ALDX)vs › | $55.25M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | -4229.63% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | -529.54% |
| 2023-09-30 | -906.84% |
| 2023-06-30 | -513.44% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | -43.65% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | -53.68% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | -61600.00% |
| 2021-09-30 | 63.45% |
| 2021-06-30 | -134.76% |
| 2021-03-31 | -103.52% |
| 2020-12-31 | -189.43% |
| 2020-09-30 | -35.31% |
| 2020-06-30 | 53.15% |
| 2020-03-31 | -291.45% |
| 2019-12-31 | -464.42% |
| 2019-09-30 | -427.30% |
| 2019-06-30 | -215.94% |
| 2019-03-31 | -883.77% |
| 2018-12-31 | -543.07% |
| 2018-09-30 | -1098.14% |
| 2018-06-30 | -392.30% |
| 2018-03-31 | -1248.98% |
| 2017-12-31 | -526.76% |
| 2017-09-30 | -299.60% |
| 2017-06-30 | -217.56% |
| 2017-03-31 | -255.23% |
| 2016-12-31 | -47.55% |
| 2016-09-30 | -113.78% |
| 2016-06-30 | -104.28% |
| 2016-03-31 | -156.86% |
| 2015-12-31 | -203.41% |
| 2015-09-30 | 65.04% |
| 2015-06-30 | -279.94% |
| 2015-03-31 | -3383.98% |
| 2014-12-31 | -3121.68% |
| 2014-09-30 | -8.68% |
| 2014-06-30 | -10159.15% |
| 2014-03-31 | -4858.95% |
| 2013-12-31 | 84.36% |
| 2013-09-30 | -1094.89% |
| 2013-06-30 | -1400.74% |
| 2013-03-31 | -891.28% |
| 2012-12-31 | 100.00% |
| 2012-09-30 | 100.00% |
| 2012-06-30 | 100.00% |
| 2012-03-31 | 100.00% |
| 2011-12-31 | 100.00% |
| 2011-09-30 | 100.00% |
| 2011-06-30 | 100.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-06-30 | 0.00% |
| 2010-03-31 | 0.00% |
| 2009-12-31 | 0.00% |
